ALXN Alexion Pharmaceuticals Inc

Alexion Pharmaceuticals, Inc. (ALXN) is currently at $123.73, up $8.89, or 7.74%

-- Would be highest close since July 10 when it closed at $124.37

-- On pace for largest percent increase since April 26, 2018, when it rose 14.5%

-- Earlier Thursday, Spanish business news website Intereconomia reported that Amgen Inc. is poised to buy Alexion Pharmaceuticals Inc. for about $45 billion, renewing speculation on a potential deal that has been rumored for more than a year

-- Currently up five of the past six days

-- Currently up two consecutive days; up 11.04% over this period

-- Best two-day stretch since the two days ending April 27, 2018, when it rose 14.46%

-- Up 9.22% month-to-date

-- Up 27.09% year-to-date

-- Down 40.47% from its all-time closing high of $207.84 on July 23, 2015

-- Traded as high as $125.52; highest intraday level since July 10 when it hit $127.74

-- Up 9.3% at Thursday's intraday high; largest intraday percent increase since April 26, 2018, when it rose as much as 16.24%

-- Third-best performer in the S&P 500 Thursday

-- Best performer in the Nasdaq 100 Thursday

All data as of 3:25 p.m. EDT

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 22, 2019 15:53 ET (19:53 GMT)

Alexion Pharmaceuticals (NASDAQ:ALXN)
Historical Stock Chart
From Mar 2024 to Apr 2024

Alexion Pharmaceuticals (NASDAQ:ALXN)
Historical Stock Chart
From Apr 2023 to Apr 2024